GlassScriptPhysician profile
Anthony Crofton May
NPI 1780614107
$2,167.71
in general payments reported to CMS, 2019-2025
12 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.51 · 2020: $177 · 2021: $44.57 · 2022: $157 · 2023: $341 · 2024: $690 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488 · Travel and Lodging: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,487.61 |
| Travel and Lodging | $219.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $920.72 | 2021-2025 | |
| Medtronic, INC. | $561.28 | 2024-2025 | Percept PC Brainsense |
| Alexion Pharmaceuticals, INC. | $200.00 | 2025 | Ultomiris |
| Allergan, INC. | $152.54 | 2020 | |
| Axsome Therapeutics, INC. | $98.58 | 2025 | Symbravo |
| Greenwich Biosciences, INC. | $82.51 | 2019 | |
| Biogen, INC. | $59.66 | 2025 | Zurzuvae |
| Pfizer INC. | $35.40 | 2025 | |
| Neuropace, INC. | $18.75 | 2023 | |
| Ucb, INC. | $14.12 | 2023 | |
| Sunovion Pharmaceuticals INC. | $12.99 | 2020 | |
| Akcea Therapeutics, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.